humanitarian
Archived signal Translated · Русский · 2–5m lag
Доклад об оценке состояния окружающей среды в Европе (EPAR): zolsketil pegilated liposomal, dexorubicin, дата получения разрешения: 31/05/2022, пересмотр: 5, статус: санкционировано
Доклад об оценке состояния окружающей среды в Европе (EPAR): Ahzanive, ablibercept, дата получения разрешения: 13/01/2025, пересмотренный вариант: 6, статус: санкционировано
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewДоклад об оценке состояния окружающей среды в Европе (EPAR): zolsketil pegilated liposomal, dexorubicin, дата получения разрешения: 31/05/2022, пересмотр: 5, статус: санкционированоEMA What Is NewДоклад об оценке состояния окружающей среды в Европе (EPAR): zolsketil pegilated liposomal, dexorubicin, дата получения разрешения: 31/05/2022, пересмотр: 5, статус: санкционированоEMA What Is NewHuman medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Date of authorisation: 13/11/2013, Revision: 17, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Xofigo, radium Ra223 dichloride, Date of authorisation: 13/11/2013, Revision: 17, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tookad, padeliporfin, Date of authorisation: 10/11/2017, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tookad, padeliporfin, Date of authorisation: 10/11/2017, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Jevtana, cabazitaxel, Date of authorisation: 17/03/2011, Revision: 25, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Jevtana, cabazitaxel, Date of authorisation: 17/03/2011, Revision: 25, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Firmagon, degarelix, Date of authorisation: 17/02/2009, Revision: 19, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Firmagon, degarelix, Date of authorisation: 17/02/2009, Revision: 19, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 6, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 6, Status: Authorised1 recorded state
Signal first indexedP2 · 99% quality · 2 sources